American Academy of Dermatology Annual Meeting

Neal Walker, MD: Investigating a Topical Treatment for Warts

March 15, 2019

Article

There are currently no FDA-approved prescription treatments for common warts, instead dermatologists must rely on painful alternatives like cutting, burning, and freezing.

Patrick Burnett, MD, PhD: Pipeline Progress of VP-102 for Molluscum Contagiosum

March 15, 2019

Article

Following the completion of 2 pivotal trials, a new drug application for VP-102 will be submitted later this year.

Simon Murray, MD: Diagnosis and Treatment of Onychomycosis

March 12, 2019

Article

Onychomycosis—fungal infection of the nail—is a common medical problem. Treatments are widely available, but relapse is common.

Larry Green, MD: Efficacy of Halobetasol & Tazarotene Lotion

March 11, 2019

Article

In a post hoc analysis, Green and colleagues examined the effect of halobetasol and tazarotene lotion on plaque psoriasis in a Hispanic population.

Larry Green, MD: Halobetasol & Tazarotene Lotion in a Hispanic Population

March 10, 2019

Article

Green introduces the combination lotion tested in this clinical trial of patients with moderate-to-sever plaque psoriasis.

Simon Murray, MD: AAD Recommendations for Acne Treatment

March 09, 2019

Article

Recommendations for acne treatment drawn from AAD position paper and presentations.

Ken Gordon, MD: Role of Placebo in the UltIMMa Trials

March 08, 2019

Article

Even in trials like UltIMMA that compare 2 drugs, a placebo control grounds the data, says Ken Gordon, MD.

James Q. Del Rosso, DO: Unlocking Isotretinoin's Benefits

March 08, 2019

Article

The nodular acne therapy has been a staple treatment for 3 decades, yet new AAD data showed it could still be better utilized in patients.

John Durkin, MD: Confocal Microscopy and its Benefits

March 05, 2019

Article

Confocal microscopy is an emerging technique that can offer a non-invasive alternative to biopsy.

Hyperhidrosis Associated with Higher Anxiety, Depression, ADD

March 05, 2019

Article

The prevalence of anxiety, depression, and ADD was higher in patients with this excessive sweating disorder than the general population.

x